The role of thalidomide in myeloma patients eligible for high-dose therapy

被引：0
|
作者：
Cavo, M. [1 ]
机构：
[1] Univ Bologna, Sch Med, Seragnoli Inst Hematol & Med Oncol, Bologna, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：28 / 29
页数：2
相关论文
共 50 条
  • [21] Role of Consolidation Therapy in Transplant Eligible Multiple Myeloma Patients
    Cavo, Michele
    Brio, Annamaria
    Tacchetti, P.
    Zannetti, B. A.
    Mancuso, K.
    Zamagni, E.
    SEMINARS IN ONCOLOGY, 2013, 40 (05) : 610 - 617
  • [22] High-dose melphalan in patients with multiple myeloma
    Moreau, P
    Le Bonniec, M
    Harousseau, JL
    BULLETIN DU CANCER, 1999, 86 (03) : 283 - 288
  • [23] An incremental response to high-dose therapy in multiple myeloma
    Hawkins, T
    Horvath, N
    Rawling, C
    Bayly, J
    Andary, C
    Dyson, P
    Ho, J
    Dart, G
    Juttner, C
    To, B
    BONE MARROW TRANSPLANTATION, 1996, 17 (06) : 929 - 935
  • [24] High-dose therapy and immunomodulatory drugs in multiple myeloma
    Barlogie, B
    Shaughnessy, J
    Zangari, M
    Tricot, G
    SEMINARS IN ONCOLOGY, 2002, 29 (06) : 26 - 33
  • [25] Infections in Patients with Multiple Myeloma in the Era of High-Dose Therapy and Novel Agents
    Nucci, Marcio
    Anaissie, Elias
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (08) : 1211 - 1225
  • [26] Daily low dose thalidomide plus monthly high-dose dexamethasoneas consolidation/maintenance treatment in elderly multiple myeloma patients
    Gentile, M.
    Mazzone, C.
    Iorio, C.
    Lucia, E.
    Vigna, E.
    Mazzei, F.
    Carnevale, P.
    Bisconte, M. G.
    Gentile, C.
    Morabito, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 93 - 93
  • [27] Single-agent thalidomide for treatment of first relapse following high-dose chemotherapy in patients with multiple myeloma
    Fenk, R
    Hoyer, B
    Steidl, U
    Kondakci, M
    Graef, T
    Heuk, R
    Ruf, L
    Strupp, C
    Neumann, F
    Rohr, UP
    Hildebrandt, B
    Haas, R
    Kobbe, G
    LEUKEMIA, 2005, 19 (01) : 156 - 159
  • [28] In vitro dendritic cell generation and lymphocyte subsets in myeloma patients:: influence of thalidomide and high-dose chemotherapy treatment
    Schütt, P
    Buttkereit, U
    Brandhorst, D
    Lindemann, M
    Schmiedl, S
    Grosse-Wilde, H
    Seeber, S
    Nowrousian, MR
    Opalka, B
    Moritz, T
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2005, 54 (05) : 506 - 512
  • [29] Thalidomide maintenance following high-dose melphalan with autologous stem cell support in myeloma
    Chang, Julie E.
    Juckett, Mark B.
    Callander, Natalie S.
    Kahl, Brad S.
    Gangnon, Ronald E.
    Mitchell, Teri L.
    Longo, Walter L.
    CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (03): : 153 - 158
  • [30] In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment
    Philipp Schütt
    Ulrike Buttkereit
    Dieter Brandhorst
    Monika Lindemann
    Sven Schmiedl
    Hans Grosse-Wilde
    Siegfried Seeber
    Mohammad Resa Nowrousian
    Bertram Opalka
    Thomas Moritz
    Cancer Immunology, Immunotherapy, 2005, 54 : 506 - 512
12345